Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2015
DOI: 10.1089/ars.2013.5594
|View full text |Cite
|
Sign up to set email alerts
|

Mitochondrially Targeted Vitamin E Succinate Modulates Expression of Mitochondrial DNA Transcripts and Mitochondrial Biogenesis

Abstract: Our data indicate a novel, selective anti-cancer activity of compounds that act by targeting mitochondria of cancer cells, inducing significant alterations in mitochondrial function associated with transcription of mtDNA-coded genes. These changes subsequently result in the arrest of cell proliferation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
31
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
6
3

Relationship

2
7

Authors

Journals

citations
Cited by 42 publications
(37 citation statements)
references
References 68 publications
0
31
0
Order By: Relevance
“…428 The antitumor effects of MitoVE 11 S were also linked to its antiangiogenic activity, and inhibition of mitochondrial DNA transcription and mitogenesis were observed both in vitro and in vivo. 429,430 Interestingly, MitoVE 11 S efficiently blocked the proliferation of both VES-sensitive and VES-resistant cell lines. 431 Although it was assumed that the succinate moiety was important for interaction with mitochondrial complex II, the susceptibility of mitochondria-targeted vitamin E succinate (MitoVES) to intracellular hydrolysis, and the anticancer effects of MitoVE 11 S were not compared with its hydrolyzed analog, MitoVE 11 .…”
Section: Mitochondria-targeted Bioactive Compounds As Potential Thmentioning
confidence: 96%
“…428 The antitumor effects of MitoVE 11 S were also linked to its antiangiogenic activity, and inhibition of mitochondrial DNA transcription and mitogenesis were observed both in vitro and in vivo. 429,430 Interestingly, MitoVE 11 S efficiently blocked the proliferation of both VES-sensitive and VES-resistant cell lines. 431 Although it was assumed that the succinate moiety was important for interaction with mitochondrial complex II, the susceptibility of mitochondria-targeted vitamin E succinate (MitoVES) to intracellular hydrolysis, and the anticancer effects of MitoVE 11 S were not compared with its hydrolyzed analog, MitoVE 11 .…”
Section: Mitochondria-targeted Bioactive Compounds As Potential Thmentioning
confidence: 96%
“…For example, mitochondrial proteins, such as Lon protease, Mitofusin-2, and TFAM, among others, may be potential therapeutic targets [157] for bladder cancer. Mitochondrially targeted vitamin E succinate (MitoVES) [158] can influence mtDNA transcripts, inhibit mitochondrial respiration, reduce the generation of reactive oxygen species, and thus suppress the proliferation of cancer cells. A photochemotherapy (PCT) [159] strategy targeting mtDNA using near-infrared (NIR)-assisted tumor-specific Fenton reactions has also been proposed.…”
Section: Ctdna and Tumor Metabolismmentioning
confidence: 99%
“…Cells were seeded on glass-bottom microscopy dishes coated with poly-L-lysine. Images were recorded the third day after seeding using 63x oil immersion lens of the SP5 confocal microscope (Leica Microsystems, Wetzlar, Germany) equipped with a heated CO 2 incubator as described in detail before (53). Time-lapse images were recorded every 5 min with the first image taken 5 min before adding the drug.…”
Section: Time-lapse Confocal Microscopymentioning
confidence: 99%